Drug therapy for the treatment of chronic heart failure and concomitant diseases // Medikation in der Behandlung der chronischen Herzinsuffizienz und Begleiterkrankungen

Shapovalenko TV; Zinchenko NM; Imanmadiyeva DM; Dolinnaya VT

Shapovalenko TV et al.

Drug therapy for the treatment of chronic heart failure and concomitant diseases // Medikation in der Behandlung der chronischen Herzinsuffizienz und Begleiterkrankungen

Zeitschrift für Gefäßmedizin 2020; 17 (4): 12-21

Volltext (PDF) Summary Abbildungen

Abbildung

Vollbildansicht	Coenzyme Q10 Abbildung 1: Effects of coenzyme Q10 on diastolic function in patients with ischemic chronic heart failure with preserved LV ejection fraction (EF > 40%), type 2 diabetes mellitus and myocardial dyssynchronicity. *Significance level (p < 0.05) compared to diastolic function in the patients on standard therapy Keywords: Diagramm, Gefäßmedizin


Vollbildansicht	Coenzyme Q10 Abbildung 2: Effects of coenzyme Q10 on cardiac dyssynchronicity in the patients with ischemic chronic heart failure with preserved LV ejection fraction (EF > 40%), type 2 diabetes mellitus and myocardial dyssynchronicity. *Significance level (p < 0.05) compared to diastolic function in the patients on standard therapy Keywords: Diagramm, Gefäßmedizin


Vollbildansicht	Coenzyme Q10 Abbildung 3: Effect of coenzyme Q10 on inflammation in patients with ischemic chronic heart failure with preserved LV ejection fraction (EF > 40%), type 2 diabetes mellitus and myocardial dyssynchronicity. *Significance level (p < 0.05) compared to diastolic function in the patients on standard therapy Keywords: Diagramm, Gefäßmedizin